Landscapes / Companies
Lantheus Medical Imaging not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
3
in active trials · 5 in all
Trials
3 active
7 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2/3 | 30 Sep 2029Phase 2/3 trial completes | |||
| Next date | 30 Sep 2029 · Phase 2/3 trial completes | ||||
| Also tested for | Prostate Cancer | ||||
| Open drug page | |||||
— |
Phase 1/2 | Aug 2027Phase 1/2 trial completes | |||
| Next date | Aug 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Relapsed / Refractory Osteosarcoma | ||||
| Open drug page | |||||
64Cu-LNTH-1363Snot checked |
— |
Phase 1/2 | — | ||
| Also tested for | Metastatic Sarcoma, Esophageal Cancer and 4 more | ||||
| Open drug page | |||||
About
- No active trial
- DEFINITY, Piflufolastat F
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021